# Infinant Health

> Infinant Health (formerly Evolve Biosystems) is a privately held life-sciences company
> in Sacramento, California, spun out of the Foods for Health Institute at the University
> of California, Davis. It commercializes B. infantis EVC001 — a strain of Bifidobacterium
> longum subsp. infantis that metabolizes human milk oligosaccharides — as the consumer
> infant probiotic Evivo, and is developing INF108 as a drug candidate aimed at reducing
> necrotizing enterocolitis in premature infants.

This file was generated by API Evangelist from the public apis.json profile at
https://apis.io/provider/evolve-biosystems. It is not published by Infinant Health.

## API surface

Infinant Health publishes NO public API, developer portal, SDK, CLI, MCP server, agent
card, or machine-readable API contract. As of 2026-08-12 every discovery probe missed:

- https://www.infinanthealth.com/openapi.json — 404
- https://www.infinanthealth.com/swagger.json — 404
- https://www.infinanthealth.com/api-docs — 404
- https://www.infinanthealth.com/llms.txt — 404
- https://www.infinanthealth.com/.well-known/agent-card.json — 404
- https://www.evivo.com/openapi.json — 404
- api.infinanthealth.com / developer.infinanthealth.com / docs.infinanthealth.com — DNS NXDOMAIN
- No GitHub organization; no first-party packages on npm, PyPI, or other registries

Do not attempt to call an Infinant Health API. None is documented.

## Company

- [Home](https://www.infinanthealth.com/): Company overview and Evivo product information
- [Our Story](https://www.infinanthealth.com/about/our-story): UC Davis origin and founding scientists
- [Our Science](https://www.infinanthealth.com/about/our-science): B. infantis EVC001 and HMO utilization
- [Our Team](https://www.infinanthealth.com/about/our-teams): Leadership and scientific team
- [Clinical Trials](https://www.infinanthealth.com/clinicaltrials): Ongoing and completed trials
- [Publications](https://www.infinanthealth.com/publications): Peer-reviewed research
- [For Investors](https://www.infinanthealth.com/for-investors): Investor information

## News and support

- [Blog](https://www.infinanthealth.com/blog): Company blog
- [Press](https://www.infinanthealth.com/press): Press releases
- [In The Press](https://www.infinanthealth.com/in-the-press): External coverage
- [Contact Us](https://www.infinanthealth.com/contact-us): customerservice@infinanthealth.com
- [Newsletter](https://www.infinanthealth.com/newsletter-subscribe): Email signup

## Products

- [Evivo](https://www.evivo.com/): Consumer infant probiotic containing B. infantis EVC001
- INF108: Investigational drug strain for prevention of necrotizing enterocolitis (no public page)

## Legal

- [Terms of Service](https://www.infinanthealth.com/terms-of-service)
- [Privacy Policy](https://www.infinanthealth.com/privacy)